These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: 1,25(OH)2 D3 blocks IFNβ production through regulating STING in epithelial layer of oral lichen planus.
    Author: Ge X, Wang Y, Xie H, Li R, Zhang F, Zhao B, Du J.
    Journal: J Cell Mol Med; 2022 Jul; 26(13):3751-3759. PubMed ID: 35644988.
    Abstract:
    Stimulator of interferon genes (STING) is reported to exert vital functions in inflammatory responses and autoimmune diseases. Nevertheless, the status and roles of STING in oral lichen planus (OLP) remain elusive. Here, we state that STING and its downstream cytokine interferon-β (IFNβ) expression is boosted in the oral keratinocytes from patients suffering OLP in comparison with those from healthy participants. Mechanistically, transcription factor GATA-binding protein 1 (GATA1) which is highly increased in diseased samples specifically interacts with its element in the promoter of STING to enhance STING transcripts. 1,25(OH)2 D3 , the active form of vitamin D, is capable of restricting STING and IFNβ increases in oral keratinocyte models resembling OLP in vitro. Moreover, there is a negative correlation between vitamin D receptor (VDR) and STING or IFNβ in human samples. Using plasmids and small interfering RNA transfection technologies, we find 1,25(OH)2 D3 regulates STING and IFNβ through a mechanism controlled by the hypoxia-inducible factor-1α (HIF-1α)-GATA1 axis. Collectively, our findings unveil that 1,25(OH)2 D3 lowers STING and IFNβ overexpression in the context of OLP.
    [Abstract] [Full Text] [Related] [New Search]